Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 4, 2009, Pages 297-306

  Li, Zhiqiang ^a   Park, Tae Sik ^b   Li, Yan ^a   Pan, Xiaoyue ^a   Iqbal, Jahangir ^a   Lu, David ^a   Tang, Weiqing ^c   Yu, Liqing ^c   Goldberg, Ira J ^b   Hussain, M Mahmood ^a   Jiang, Xian Cheng ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cholesterol absorption; Dyslipidemia; Myriocin; SPT gene knockout

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G5; CARRIER PROTEIN; CHOLESTEROL; PROTEIN NPC1L1; SERINE PALMITOYLTRANSFERASE; THERMOZYMOCIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME INHIBITION; HETEROZYGOTE; INTESTINE ABSORPTION; INTESTINE CELL; KNOCKOUT MOUSE; LIPID ABSORPTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

ABSORPTION; ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CHOLESTEROL; ENTEROCYTES; ENZYME INHIBITORS; FATTY ACIDS, MONOUNSATURATED; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIPID METABOLISM; LIPOPROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE C-PALMITOYLTRANSFERASE; TOXINS, BIOLOGICAL; TRIGLYCERIDES;

ANIMALIA; MUS;

EID: 62249186734     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.01.010     Document Type: Article

References (44)

1. Gylling H., and Miettinen T.A. The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis 117 (1995) 305-308
2. Altmann S.W., Davis Jr. H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., Iyer S.P., Maguire M., Golovko A., Zeng M., Wang L., Murgolo N., and Graziano M.P. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303 (2004) 1201-1204
3. Garcia-Calvo M., Lisnock J., Bull H.G., Hawes B.E., Burnett D.A., Braun M.P., Crona J.H., Davis Jr. H.R., Dean D.C., Detmers P.A., Graziano M.P., Hughes M., Macintyre D.E., Ogawa A., O'neill K.A., Iyer S.P., Shevell D.E., Smith M.M., Tang Y.S., Makarewicz A.M., Ujjainwalla F., Altmann S.W., Chapman K.T., and Thornberry N.A. The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8132-8137
4. Yu L., Bharadwaj S., Brown J.M., Ma Y., Du W., Davis M.A., Michaely P., Liu P., Willingham M.C., and Rudel L.L. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J. Biol. Chem. 281 (2006) 6616-6624
5. Yu L., York J., von Bergmann K., Lutjohann D., Cohen J.C., and Hobbs H.H. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J. Biol. Chem. 278 (2003) 15565-15570
6. Iqbal J., and Hussain M.M. Evidence for multiple complementary pathways for efficient cholesterol absorption in mice. J. Lipid Res. 46 (2005) 1491-1501
7. Iqbal J., Anwar K., and Hussain M.M. Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells. J. Biol. Chem. 278 (2003) 31610-31620
8. Merrill A.H., and Jones D.D. An update of the enzymology and regulation sphingomyelin metabolism. Biochim. Biophysi. Acta. 1044 (1990) 1-12
9. Weiss B., and Stoffel W. Human and murine serine-palmitoyl-CoA transferase - cloning, expression and characterization of the key enzyme in sphingolipid synthesis. Eur. J. Biochem. 249 (1997) 239-247
10. Hanada K., Hara T., Nishijima M., Kuge O., Dickson R.C., and Nagiec M.M. A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis. J. Biol. Chem. 272 (1997) 32108-32114
11. Hornemann T., Richard S., Rütti M.F., Wei Y., and von Eckardstein A. Mammalian serine-palmitoyltransferase - cloning and initial characterisation of a new subunit. J. Biol. Chem. 281 (2006) 37275-37281
12. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
13. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1726
14. Li Z., Hailemariam T.K., Zhou H., Li Y., Duckworth D.C., Peake D.A., Zhang Y., Kuo M.S., Cao G., and Jiang X.C. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim. Biophys. Acta. 1771 (2007) 1186-1194
15. Christiansen K., and Carlsen J. Microvillus membrane vesicles from pig small intestine. Purity and lipid composition. Biochim. Biophys. Acta 647 (1981) 188-195
16. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
17. Field F.J., Born E., Murthy S., and Mathur S.N. Caveolin is present in intestinal cells: role in cholesterol trafficking?. J. Lipid Res. 39 (1998) 1938-1950
18. Graf G.A., Yu L., Li W.P., Gerard R., Tuma P.L., Cohen J.C., and Hobbs H.H. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J. Biol. Chem. 278 (2003) 48275-48282
19. Park T.S., Panek R.L., Mueller S.B., Hanselman J.C., Rosebury W.S., Robertson A.W., Kindt E.K., Homan R., Karathanasis S.K., and Rekhter M.D. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 110 (2004) 3465-3471
20. Sehayek E., Ono J.G., Shefer S., Nguyen L.B., Wang N., Batta A.K., Salen G., Smith J.D., Tall A.R., and Breslow J.L. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10194-10199
21. Wang D.Q., and Carey M.C. Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J. Lipid Res. 44 (2003) 1042-1059
22. Carr T.P., Andresen C.J., and Rudel L.L. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26 (1993) 39-42
23. Hojjati M.R., and Jiang X.C. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J. Lipid Res. 47 (2006) 673-676
24. Hojjati M.R., Li Z., and Jiang X.C. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim. Biophys. Acta. 1737 (2005) 44-51
25. Kiyokawa E., Baba T., Otsuka N., Makino A., Ohno S., and Kobayashi T. Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J. Biol. Chem. 280 (2005) 24072-24084
26. Ishitsuka R., and Kobayashi T. Cholesterol and lipid/protein ratio control the oligomerization of a sphingomyelin-specific toxin, lysenin. Biochemistry 46 (2007) 1495-1502
27. Hojjati M.R., Li Z., Zhou H., Tang S., Huan C., Ooi E., Lu S., and Jiang X.C. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J. Biol. Chem. 280 (2005) 10284-10289
28. Glaros E.N., Kim W.S., Wu B.J., Suarna C., Quinn C.M., Rye K.A., Stocker R., Jessup W., and Garner B. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochem. Pharmacol. 73 (2007) 1340-1346
29. Park T.S., Panek R.L., Rekhter M.D., Mueller S.B., Rosebury W.S., Robertson A., Hanselman J.C., Kindt E., Homan R., and Karathanasis S.K. Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice. Atherosclerosis 189 (2006) 264-272
30. Park T.S., Rosebury W., Kindt E.K., Kowala M.C., and Panek R.L. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. Pharmacol. Res. 58 (2008) 45-51
31. Bodary P.F., Shen Y., Vargas F.B., Bi X., Ostenso K.A., Gu S., Shayman J.A., and Eitzman D.T. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency. Circulation 111 (2005) 629-632
32. Weisgraber K.H., Innerarity T.L., Rall Jr. S.C., and Mahley R.W. Receptor interactions controlling lipoprotein metabolism. Can. J. Biochem. Cell Biol. 63 (1985) 898-905
33. Jeong T.S., Schissel S.L., Tabas I., Pownall H.J., Tall A.R., and Jiang X.C. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101 (1998) 905-912
34. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., and Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290 (2000) 1771-1775
35. Salen G., Tint G.S., Shefer S., Shore V., and Nguyen L. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler. Thromb. 12 (1992) 563-568
36. Wang H.H., Patel S.B., Carey M.C., and Wang D.Q. Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hepatology 45 (2007) 998-1006
37. Yu L., Li-Hawkins J., Hammer R.E., Berge K.E., Horton J.D., Cohen J.C., and Hobbs H.H. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110 (2002) 671-680
38. Brunham L.R., Kruit J.K., Iqbal J., Fievet C., Timmins J.M., Pape T.D., Coburn B.A., Bissada N., Staels B., Groen A.K., Hussain M.M., Parks J.S., Kuipers F., and Hayden M.R. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116 (2006) 1052-1062
39. Gaus K., Kritharides L., Schmitz G., Boettcher A., Drobnik W., Langmann T., Quinn C.M., Death A., Dean R.T., and Jessup W. Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J. 18 (2004) 574-576
40. Davis Jr. H.R., Zhu L.J., Hoos L.M., Tetzloff G., Maguire M., Liu J., Yao X., Iyer S.P., Lam M.H., Lund E.G., Detmers P.A., Graziano M.P., and Altmann S.W. Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J. Biol. Chem. 279 (2004) 33586-33592
41. Witting S.R., Maiorano J.N., and Davidson W.S. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J. Biol. Chem. 278 (2003) 40121-40127
42. Ghering A.B., and Davidson W.S. Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I. J. Lipid Res. 47 (2006) 2781-2788
43. Klingenberg R., Nofer J.R., Rudling M., Bea F., Blessing E., Preusch M., Grone H.J., Katus H.A., Hansson G.K., and Dengler T.J. Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2392-2399
44. Diaz O., Mébarek-Azzam S., Benzaria A., Dubois M., Lagarde M., Némoz G., and Prigent A.F. Disruption of lipid rafts stimulates phospholipase d activity in human lymphocytes: implication in the regulation of immune function. J. Immunol. 175 (2005) 8077-8086